🇺🇸 Hormonal treatment in United States

24 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Aspartate Aminotransferase Increased — 3 reports (12.5%)
  2. Embolism — 3 reports (12.5%)
  3. Peripheral Sensory Neuropathy — 3 reports (12.5%)
  4. Thrombosis — 3 reports (12.5%)
  5. Anaemia — 2 reports (8.33%)
  6. Cerebral Ischaemia — 2 reports (8.33%)
  7. Dyspnoea — 2 reports (8.33%)
  8. Fatigue — 2 reports (8.33%)
  9. Febrile Neutropenia — 2 reports (8.33%)
  10. Hypersensitivity — 2 reports (8.33%)

Source database →

Hormonal treatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Hormonal treatment approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hormonal treatment in United States?

Sohag University is the originator. The local marketing authorisation holder may differ — check the official source linked above.